Cypress Capital Management (Wyoming)’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-50	Closed	-$2.03K	–	167
2022 Q4	$2.03K	Hold	50	–	–	﹤0.01%	140
2022 Q3	$3K	Hold	50	–	–	﹤0.01%	133
2022 Q2	$3K	Buy	+50	New	+$3K	﹤0.01%	142